Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Country, Market attractiveness

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Surging Prevalence of Infectious Disease Globally

4.1.2 Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases

4.2 Market Restraints

4.2.1 Limitations Associated with Molecular Testing

4.3 Market Opportunities

4.3.1 Advancements in Molecular Diagnostics Technologies

4.4 Future Trends

4.4.1 Molecular Diagnostics for Infectious Diseases in Personalized Medicine

4.5 Impact Analysis:

5. Molecular Diagnostic for Infectious Diseases Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030

6. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Type

6.1 Overview

6.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)

6.3 Point-of-Care Testing

6.3.1 Overview

6.3.2 Point-of-Care Testing: Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Laboratory Testing

6.4.1 Overview

6.4.2 Laboratory Testing: Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by End User

7.1 Overview

7.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)

7.2.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

7.2.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

8. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Application

8.1 Overview

8.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)

8.3 Point-of-Care Testing

8.3.1 Overview

8.3.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

8.4 Laboratory Testing

8.4.1 Overview

8.4.2 Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

9. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Disease Type

9.1 Overview

9.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)

9.3 Point-of-Care Testing

9.3.1 Overview

9.3.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

9.3.2.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

9.4 Laboratory Testing

9.4.1 Overview

9.4.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

9.4.2.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

10. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Infection Type

10.1 Overview

10.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)

10.3 Point-of-Care Testing

10.3.1 Overview

10.3.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

10.4 Laboratory Testing

10.4.1 Overview

10.4.2 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Country Analysis

11.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030

11.1.1 Overview

11.1.1.1 Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Country

11.1.1.2 Saudi Arabia

11.1.1.2.1 Saudi Arabia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.2.3 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.2.4 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.2.5 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.2.6 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.2.7 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.2.7.1 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.2.8 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.2.8.1 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.2.9 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.2.10 Saudi Arabia: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.3 South Africa

11.1.1.3.1 South Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 South Africa: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.3.3 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.3.4 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.3.5 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.3.6 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.3.7 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.3.7.1 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.3.8 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.3.8.1 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.3.9 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.3.10 South Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.4 UAE

11.1.1.4.1 UAE Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 UAE: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.4.3 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.4.4 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.4.5 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.4.6 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.4.7 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.4.7.1 UAE: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.4.8 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.4.8.1 UAE: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.4.9 UAE: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.4.10 UAE: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.5 Rest of Middle East & Africa

11.1.1.5.1 Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.5.2 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.5.3 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.5.4 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.5.5 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.5.6 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.5.7 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.5.7.1 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.5.8 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.5.8.1 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.5.9 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.5.10 Rest of Middle East & Africa: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Abbott Laboratories

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Thermo Fisher Scientific Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 bioMerieux SA

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Danaher Corp

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Hologic Inc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens Healthineers AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Bruker Corp

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DiaSorin SpA

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Segmentation

Table 2. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point of Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 3. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 4. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 5. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 6. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 7. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 8. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 9. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 10. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 11. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 15. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 17. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 18. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 19. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 20. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 21. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 22. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 23. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 24. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 25. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 27. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 28. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 29. South Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 30. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 31. South Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 32. South Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 33. South Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 34. UAE Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 35. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 36. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 37. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 38. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 39. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 40. UAE Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 41. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 42. UAE Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 43. UAE Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 44. UAE Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 45. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 46. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 47. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 48. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 49. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 50. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 51. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 52. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 53. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 54. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 55. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 56. Organic Developments Done By Companies

Table 57. Inorganic Developments Done By Companies

Table 58. Glossary of Terms, Molecular Diagnostic for Infectious Diseases Market

List of Figures

Figure 1. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Segmentation, By Country

Figure 2. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)

Figure 6. Point-of-Testing: Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Laboratory Testing: Middle East & Africa Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)

Figure 9. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)

Figure 10. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)

Figure 11. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)

Figure 12. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 13. Middle East & Africa Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)

Figure 14. Saudi Arabia Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 15. South Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 16. UAE Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 17. Rest of Middle East & Africa Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 18. Growth Strategies Done by the Companies in the Market, (%)